Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain

• Autori principali: Lister J (Autore), Stanisic S (Autore), Kaier K (Autore), Hagist C (Autore), Gultyaev D (Autore), Walzer S (Autore)
• Natura: Libro
• Pubblicazione: Dove Medical Press, 2012-10-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Johanna Lister,1 Sanja Stanisic,1 Klaus Kaier,2 Christian Hagist,2 Dmitry Gultyaev,1 Stefan Walzer31Analytica LA-SER International Inc, Lörrach, Germany; 2Research Centre for Generational Contracts, University of Freiburg, Freiburg, Germany; 3F Hoffmann-La Roche Ltd, Pharmaceuticals Divisio...